DK1474689T3 - Fremgangsmåde til diagnosticering af inflammatoriske sygdomme ved anvendelse af calgranulin c - Google Patents
Fremgangsmåde til diagnosticering af inflammatoriske sygdomme ved anvendelse af calgranulin cInfo
- Publication number
- DK1474689T3 DK1474689T3 DK03708103.1T DK03708103T DK1474689T3 DK 1474689 T3 DK1474689 T3 DK 1474689T3 DK 03708103 T DK03708103 T DK 03708103T DK 1474689 T3 DK1474689 T3 DK 1474689T3
- Authority
- DK
- Denmark
- Prior art keywords
- diagnostication
- calgranulin
- procedure
- inflammatory diseases
- inflammatory
- Prior art date
Links
- 101710110949 Protein S100-A12 Proteins 0.000 title 1
- 102000058242 S100A12 Human genes 0.000 title 1
- 208000027866 inflammatory disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4727—Calcium binding proteins, e.g. calmodulin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Rheumatology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rehabilitation Therapy (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/077,600 US20030175713A1 (en) | 2002-02-15 | 2002-02-15 | Method for diagnosis of inflammatory diseases using CALGRANULIN C |
| PCT/EP2003/001575 WO2003069341A2 (en) | 2002-02-15 | 2003-02-17 | Method of diagnosis of inflammatory diseases using calgranulin c |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1474689T3 true DK1474689T3 (da) | 2012-12-03 |
Family
ID=27732684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03708103.1T DK1474689T3 (da) | 2002-02-15 | 2003-02-17 | Fremgangsmåde til diagnosticering af inflammatoriske sygdomme ved anvendelse af calgranulin c |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20030175713A1 (enExample) |
| EP (1) | EP1474689B1 (enExample) |
| JP (2) | JP5487404B2 (enExample) |
| AU (1) | AU2003212245A1 (enExample) |
| CA (1) | CA2474890A1 (enExample) |
| DK (1) | DK1474689T3 (enExample) |
| ES (1) | ES2394962T3 (enExample) |
| WO (1) | WO2003069341A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030224386A1 (en) * | 2001-12-19 | 2003-12-04 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis |
| US20030175713A1 (en) * | 2002-02-15 | 2003-09-18 | Clemens Sorg | Method for diagnosis of inflammatory diseases using CALGRANULIN C |
| WO2004043238A2 (en) * | 2002-11-14 | 2004-05-27 | Ciphergen Biosystems, Inc. | Biomarkers for intra-amniotic inflammation |
| ATE458201T1 (de) | 2003-12-23 | 2010-03-15 | Hoffmann La Roche | Methode zur beurteilung von rheumatoider arthritis durch bestimmung von anti-ccp und interleukin 6 |
| JP4868378B2 (ja) * | 2004-11-19 | 2012-02-01 | 株式会社明治 | 炎症性腸疾患治療薬 |
| KR101147586B1 (ko) * | 2006-05-19 | 2012-08-23 | 에프. 호프만-라 로슈 아게 | 결장직장암에 대한 마커로서 단백질 ｓ100ａ12 의 용도 |
| DE102007036678B4 (de) * | 2007-08-03 | 2015-05-21 | Sirs-Lab Gmbh | Verwendung von Polynukleotiden zur Erfassung von Genaktivitäten für die Unterscheidung zwischen lokaler und systemischer Infektion |
| WO2009049257A2 (en) * | 2007-10-11 | 2009-04-16 | Cardio Dx, Inc. | Predictive models and methods for diagnosing and assessing coronary artery disease |
| CA2702533A1 (en) * | 2007-10-19 | 2009-04-23 | Erac As | Edta resistant s100a12 complexes (erac) |
| GB0922006D0 (en) * | 2009-12-17 | 2010-02-03 | Genome Res Ltd | Diagnostic |
| WO2011146479A1 (en) * | 2010-05-18 | 2011-11-24 | The Texas A&M University System | Method and composition for the diagnosis and monitoring of inflammatory diseases |
| WO2015067913A1 (en) | 2013-11-07 | 2015-05-14 | Diagnodus Limited | Biomarkers |
| US9678084B2 (en) * | 2011-06-04 | 2017-06-13 | Rochester General Hospital Research Institute | Compositions and methods related to S100A12 |
| WO2013167727A2 (en) | 2012-05-11 | 2013-11-14 | Westfaelische Wilhelms-Universitaet Muenster | Method for determining arthritis relapse risk |
| EP3487874A1 (en) | 2016-07-20 | 2019-05-29 | Westfälische Wilhelms-Universität Münster | Complex-specific standardization of immunological methods for the quantification of s100a12 |
| US11287396B2 (en) | 2020-06-05 | 2022-03-29 | Princeton Biochemicals, Inc. | Method and system for simultaneous determination of multiple measurable biomarkers during the development of a communicable disease |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5455160A (en) * | 1993-05-27 | 1995-10-03 | Fagerhol; Magne K. | Diagnostic test and kit for disease or disorders in the digestive system |
| JPH08238091A (ja) * | 1995-03-06 | 1996-09-17 | Jiro Hitomi | 新規カルシウム結合タンパク |
| JPH08238090A (ja) * | 1995-03-06 | 1996-09-17 | Jiro Hitomi | 新規カルシウム結合タンパク |
| EP0731166A3 (en) * | 1995-03-06 | 1997-12-29 | Tonen Corporation | Novel calcium-binding proteins |
| US5976832A (en) * | 1995-03-06 | 1999-11-02 | Tonen Corporation | DNA encoding novel calcium-binding proteins |
| WO2000020621A1 (en) * | 1998-10-06 | 2000-04-13 | The Trustees Of Columbia University In The City Of New York | Extracellular novel rage binding protein (en-rage) and uses thereof |
| US7081241B1 (en) * | 1998-10-06 | 2006-07-25 | The Trustees Of Columbia University In The City Of New York | Extracellular rage binding protein (EN-RAGE) and uses thereof |
| US6028060A (en) * | 1997-01-29 | 2000-02-22 | Vanderbilt University | Treatment of chronic inflammatory diseases with CM101/GBS toxin |
| US6020135A (en) * | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
| US7011952B2 (en) * | 2000-02-22 | 2006-03-14 | University Of Iowa Research Foundation | Diagnostics and therapeutics for macular degeneration-related disorders |
| WO2001086002A2 (en) * | 2000-05-09 | 2001-11-15 | Genetics Institute, Llc | Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis |
| AU2001292846A1 (en) * | 2000-09-20 | 2002-04-29 | Surromed, Inc. | Biological markers for evaluating therapeutic treatment of inflammatory and autoimmune disorders |
| WO2002048310A2 (en) * | 2000-12-15 | 2002-06-20 | Genetics Institute, Llc | Methods and compositions for diagnosing and treating rheumatoid arthritis |
| US20030224386A1 (en) * | 2001-12-19 | 2003-12-04 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis |
| US20030175713A1 (en) * | 2002-02-15 | 2003-09-18 | Clemens Sorg | Method for diagnosis of inflammatory diseases using CALGRANULIN C |
-
2002
- 2002-02-15 US US10/077,600 patent/US20030175713A1/en not_active Abandoned
-
2003
- 2003-02-17 ES ES03708103T patent/ES2394962T3/es not_active Expired - Lifetime
- 2003-02-17 WO PCT/EP2003/001575 patent/WO2003069341A2/en not_active Ceased
- 2003-02-17 CA CA002474890A patent/CA2474890A1/en not_active Abandoned
- 2003-02-17 JP JP2003568411A patent/JP5487404B2/ja not_active Expired - Fee Related
- 2003-02-17 US US10/504,299 patent/US20050147972A1/en not_active Abandoned
- 2003-02-17 AU AU2003212245A patent/AU2003212245A1/en not_active Abandoned
- 2003-02-17 DK DK03708103.1T patent/DK1474689T3/da active
- 2003-02-17 EP EP03708103A patent/EP1474689B1/en not_active Expired - Lifetime
-
2009
- 2009-04-13 US US12/422,632 patent/US20170138931A9/en not_active Abandoned
-
2010
- 2010-10-29 JP JP2010244271A patent/JP5650985B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005517414A (ja) | 2005-06-16 |
| EP1474689A2 (en) | 2004-11-10 |
| WO2003069341A2 (en) | 2003-08-21 |
| JP5650985B2 (ja) | 2015-01-07 |
| AU2003212245A1 (en) | 2003-09-04 |
| US20100311758A1 (en) | 2010-12-09 |
| JP5487404B2 (ja) | 2014-05-07 |
| EP1474689B1 (en) | 2012-09-12 |
| US20050147972A1 (en) | 2005-07-07 |
| US20170138931A9 (en) | 2017-05-18 |
| CA2474890A1 (en) | 2003-08-21 |
| AU2003212245A8 (en) | 2003-09-04 |
| JP2011053222A (ja) | 2011-03-17 |
| ES2394962T3 (es) | 2013-02-07 |
| WO2003069341A3 (en) | 2004-02-05 |
| US20030175713A1 (en) | 2003-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2022001I2 (el) | Παραγωγα του uk-2a | |
| DK1701941T3 (da) | Forbindelser til behandling af sygdomme med celleproliferation | |
| DK1828164T3 (da) | Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider | |
| DK1778668T3 (da) | Fremgangsmåde til fremstilling af dihydropteridion | |
| DK1888033T3 (da) | Fremgangsmåde og sammensætning til behandling af inflammatoriske sygdomme | |
| DK1756679T3 (da) | Fremgangsmåde til tidsstyring af et objekt | |
| DK1474689T3 (da) | Fremgangsmåde til diagnosticering af inflammatoriske sygdomme ved anvendelse af calgranulin c | |
| DK2308507T3 (da) | Fremgangsmåder til behandling af præeklampsi | |
| DK1706112T3 (da) | Fremgangsmåder til at behandle en inflammatorisk-beslægtet sygdom | |
| DK1840125T3 (da) | Mellemprodukter til fremstilling af dioxan-2-alkylcarbamater | |
| DK1667986T3 (da) | Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf | |
| DK1478358T3 (da) | Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese | |
| ATE314808T1 (de) | Neues 2-pyridylethylbenzamid-derivat | |
| DK1608634T3 (da) | Fremgangsmåder til isolering af krystallinsk form af 5-azacytidin | |
| DK1708992T3 (da) | Sulfonamidderivater til behandling af sygdomme | |
| DK1348473T3 (da) | Elementsæt til samling af strukturer | |
| DK1637610T3 (da) | Fremgangsmåde til fremstilling af alkylestere | |
| DK1611108T3 (da) | Fremgangsmåde til fremstilling af telmisartan | |
| DK1745136T3 (da) | Fremgangsmåde til enzymatisk fremstilling af (S)-3-cyano-5-methylhexansyre | |
| DK1825484T3 (da) | Fremgangsmåde til fremstilling af kabler | |
| DK1516596T3 (da) | Forbedret system til behandling af stress-urinkontinens | |
| DK1575941T3 (da) | Fremgangsmåde til fremstilling af (S)-pantoprazol | |
| DK1519928T3 (da) | Fremgangsmåde til fremstilling af heterocykliske fluoralkenylsulfoner | |
| DK1572613T3 (da) | Fremgangsmåde til fremstilling af benzophenoner | |
| DK1687297T3 (da) | Triazindimerer til behandling af autoimmunsygdomme |